BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18678353)

  • 41. Remote-loading labeling of liposomes with (99m)Tc-BMEDA and its stability evaluation: effects of lipid formulation and pH/chemical gradient.
    Li S; Goins B; Phillips WT; Bao A
    J Liposome Res; 2011 Mar; 21(1):17-27. PubMed ID: 20334497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comprehensive radiolabeling, stability, and tissue distribution studies of technetium-99m single amino acid chelates (SAAC).
    Maresca KP; Hillier SM; Femia FJ; Zimmerman CN; Levadala MK; Banerjee SR; Hicks J; Sundararajan C; Valliant J; Zubieta J; Eckelman WC; Joyal JL; Babich JW
    Bioconjug Chem; 2009 Aug; 20(8):1625-33. PubMed ID: 19572702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation and bioevaluation of (99m)Tc-HYNIC-annexin B1 as a novel radioligand for apoptosis imaging.
    Luo QY; Wang F; Zhang ZY; Zhang Y; Lu HK; Sun SH; Zhu RS
    Apoptosis; 2008 Apr; 13(4):600-8. PubMed ID: 18307043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pyridine-tert-nitrogen-phenol ligands: N,N,O-Type tripodal chelates for the [M(CO)3]+ core (M = Re, Tc).
    Lim NC; Ewart CB; Bowen ML; Ferreira CL; Barta CA; Adam MJ; Orvig C
    Inorg Chem; 2008 Feb; 47(4):1337-45. PubMed ID: 18189350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
    Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D
    Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiolabeling and biological evaluation of the GX1 and RGD-GX1 peptide sequence for angiogenesis targeting.
    Oliveira EA; Faintuch BL
    Nucl Med Biol; 2015 Feb; 42(2):123-30. PubMed ID: 25311749
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [99mTc] HYNIC-hEGF, a potential agent for imaging of EGF receptors in vivo: preparation and pre-clinical evaluation.
    Babaei MH; Almqvist Y; Orlova A; Shafii M; Kairemo K; Tolmachev V
    Oncol Rep; 2005 Jun; 13(6):1169-75. PubMed ID: 15870939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of macrocyclic triamine ligands as synthons for organometallic 99mTc radiopharmaceuticals.
    Suzuki K; Shimmura N; Thipyapong K; Uehara T; Akizawa H; Arano Y
    Inorg Chem; 2008 Apr; 47(7):2593-600. PubMed ID: 18269240
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation, 99mTc-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr3]octreotide.
    Decristoforo C; Mather SJ
    Bioconjug Chem; 1999; 10(3):431-8. PubMed ID: 10346875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and evaluation of analogues of HYNIC as bifunctional chelators for technetium.
    Meszaros LK; Dose A; Biagini SC; Blower PJ
    Dalton Trans; 2011 Jun; 40(23):6260-7. PubMed ID: 21350776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sorbitol as a Polar Pharmacological Modifier to Enhance the Hydrophilicity of
    Giammei C; Balber T; Benčurová K; Cardinale J; Berroterán-Infante N; Brandt M; Jouini N; Hacker M; Mitterhauser M; Mindt TL
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32527027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Necrosis avidity of (99m)Tc(CO)3-labeled pamoic acid derivatives: synthesis and preliminary biological evaluation in animal models of necrosis.
    Fonge H; Chitneni SK; Lixin J; Vunckx K; Prinsen K; Nuyts J; Mortelmans L; Bormans G; Ni Y; Verbruggen A
    Bioconjug Chem; 2007; 18(6):1924-34. PubMed ID: 17929883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals.
    Bartholomä M; Valliant J; Maresca KP; Babich J; Zubieta J
    Chem Commun (Camb); 2009 Feb; (5):493-512. PubMed ID: 19283279
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Caution to HPLC analysis of tricarbonyl technetium radiopharmaceuticals: an example of changing constitution of complexes in column.
    Chen X; Guo Y; Liu B
    J Pharm Biomed Anal; 2007 Mar; 43(4):1576-9. PubMed ID: 17187955
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 99mTc-labeling of HYNIC-conjugated cyclic RGDfK dimer and tetramer using EDDA as coligand.
    Wang J; Kim YS; Liu S
    Bioconjug Chem; 2008 Mar; 19(3):634-42. PubMed ID: 18281926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [
    Kolay S; Kumar N; Guleria M; Das T
    Bioorg Med Chem Lett; 2024 Jun; 105():129730. PubMed ID: 38583784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Influence of Co-Ligands on Improving Tumor Targeting of
    Torabizadeh SA; Hosseinimehr SJ
    Mini Rev Med Chem; 2017; 17(2):86-94. PubMed ID: 27515713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [
    Mazaheri Tehrani M; Erfani M; Amirmozafari N
    Chem Biol Drug Des; 2021 Apr; 97(4):904-913. PubMed ID: 33326679
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study of the
    Kaihani S; Sadeghzadeh N
    J Labelled Comp Radiopharm; 2020 Dec; 63(14):582-596. PubMed ID: 32997359
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.